Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 13, 2022
[Primary cutaneous anaplastic large cell lymphoma with systemic progression responding to low-dose methotrexate therapy]Ryohei Sumitani, Takeshi Harada, Masafumi Nakamura, et al.
Oncotarget|April 9, 2019
PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γMasami Iwasa, Takeshi Harada, Asuka Oda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy]Shingen Nakamura, Noriaki Horiuchi, Daisuke Katsura, et al.
International Journal of Hematology|June 24, 2011
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cellsQu Cui, Hironobu Shibata, Asuka Oda, et al.
Journal of Atherosclerosis and Thrombosis|April 21, 2023
Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal PrognosisShiho Masuda, Tomoyo Hara, Hiroki Yamagami, et al.
Palliative Medicine Reports|April 10, 2024
Usefulness of Palliative Prognostic Index, Objective Prognostic Score, and Neutrophil-Lymphocyte Ratio/Albumin Ratio As Prognostic Indicators for Patients Without Cancer Receiving Home-Visit Palliative Care: A Pilot Study at a Community General HospitalTaiki Hori, Ken-Ichi Aihara, Koki Ishida, et al.
Heliyon|May 30, 2024
Humoral immune response against SARS-CoV-2 and polyethylene glycol elicited by anti-SARS-CoV-2 mRNA vaccine, and effect of pre-existing anti-polyethylene glycol antibody in patients with hematological and autoimmune diseasesTaiki Hori, Taro Shimizu, Hidenori Ando, et al.
International Journal of Hematology|October 27, 2025
Novel noninvasive parameters for diagnosis of liver involvement in patients with systemic AL amyloidosisRyohei Sumitani, Hirokazu Miki, Shingen Nakamura, et al.
Plos One|January 4, 2014
Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitorsTakeshi Harada, Shuji Ozaki, Asuka Oda, et al.
Oncotarget|October 15, 2016
Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitorsAriunzaya Bat-Erdene, Hirokazu Miki, Asuko Oda, et al.
Pageof 9